Penserra Capital Management LLC Rapt Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$29.5 - $39.5 $19,765 - $26,465	-670 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $2,986 - $3,947	100 Added 17.54%	670 $20,000
Q2 2021 Aug 12, 2021	BUY	$17.99 - $40.02 $179 - $400	10 Added 1.79%	570 $18,000
Q1 2021 May 13, 2021	SELL	$16.0 - $24.46 $80 - $122	-5 Reduced 0.88%	560 $12,000
Q4 2020 Feb 12, 2021	BUY	$15.89 - $40.87 $8,977 - $23,091	565 New	565 $11,000

100

124M

246K

69.6K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $33.5M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.